Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jeannin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis International|November 19, 2011
Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosisS Jeannin, R Deschamps, N Chausson, et al.
Revue Neurologique|April 25, 2007
[Phenotypical aspects and clinical course of multiple sclerosis in 76 patients with a North African ethnic background followed at the Nice University Hospital]S Jeannin, V Bourg, F Berthier, et al.
European Journal of Neurology|March 29, 2007
Turcot syndrome confirmed with molecular analysisC Lebrun, S Olschwang, S Jeannin, et al.
British Journal of Clinical Pharmacology|August 1, 1996
Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjectsJ L Megnien, A Simon, A Andriani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in FranceC Lebrun, M Debouverie, S Jeannin, et al.
Neurology|January 4, 2007
More severe disability of North Africans vs Europeans with multiple sclerosis in FranceM Debouverie, C Lebrun, S Jeannin, et al.
Revue Neurologique|December 17, 2009
[Cannabis-induced cerebral and myocardial infarction in a young woman]C Duchene, S Olindo, N Chausson, et al.
Revue Neurologique|September 23, 2008
[Actinomycosis: an unusual cause of spinal cord compression. Case report and review of the literature]S Jeannin, A Benchikh El Fegoun, S Debruxelles, et al.
Revue Neurologique|July 15, 2006
[Turcot's syndrome confirmed by molecular biological tests]S Jeannin, C Lebrun, F Van Den Bos, et al.
Journal of Neurology|February 19, 2018
Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter studyPhilippe Cabre, M Mejdoubi, S Jeannin, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis International|November 19, 2011
Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosisS Jeannin, R Deschamps, N Chausson, et al.
Revue Neurologique|April 25, 2007
[Phenotypical aspects and clinical course of multiple sclerosis in 76 patients with a North African ethnic background followed at the Nice University Hospital]S Jeannin, V Bourg, F Berthier, et al.
European Journal of Neurology|March 29, 2007
Turcot syndrome confirmed with molecular analysisC Lebrun, S Olschwang, S Jeannin, et al.
British Journal of Clinical Pharmacology|August 1, 1996
Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjectsJ L Megnien, A Simon, A Andriani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in FranceC Lebrun, M Debouverie, S Jeannin, et al.
Neurology|January 4, 2007
More severe disability of North Africans vs Europeans with multiple sclerosis in FranceM Debouverie, C Lebrun, S Jeannin, et al.
Revue Neurologique|December 17, 2009
[Cannabis-induced cerebral and myocardial infarction in a young woman]C Duchene, S Olindo, N Chausson, et al.
Revue Neurologique|September 23, 2008
[Actinomycosis: an unusual cause of spinal cord compression. Case report and review of the literature]S Jeannin, A Benchikh El Fegoun, S Debruxelles, et al.
Revue Neurologique|July 15, 2006
[Turcot's syndrome confirmed by molecular biological tests]S Jeannin, C Lebrun, F Van Den Bos, et al.
Journal of Neurology|February 19, 2018
Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter studyPhilippe Cabre, M Mejdoubi, S Jeannin, et al.
Pageof 2